UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

The New England journal of medicine, 2013-08, Vol.369 (8), p.722-731

2013

Volltextzugriff (PDF)

Machine learning for the prediction of minor amputation in University of Texas grade 3 diabetic foot ulcers

PloS one, 2022-12, Vol.17 (12), p.e0278445-e0278445

2022

Volltextzugriff (PDF)

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

Journal of hematology and oncology, 2016-10, Vol.9 (1), p.105-105, Article 105

2016

Volltextzugriff (PDF)

Machine learning for the prediction of minor amputation in University of Texas grade 3 diabetic foot ulcers

PloS one, 2022-12, Vol.17 (12), p.e0278445

2022

Volltextzugriff (PDF)

Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015-01, Vol.18 (1), p.168-176

2015

Volltextzugriff (PDF)

Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial

International journal of clinical oncology, 2021-09, Vol.26 (9), p.1611-1618

2021

Volltextzugriff (PDF)

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-01, Vol.19 (1), p.234-244

2016

Volltextzugriff (PDF)

Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies

BMC cancer, 2020-03, Vol.20 (1), p.219-219, Article 219

2020

Volltextzugriff (PDF)

Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial

Frontiers in oncology, 2020-05, Vol.10, p.664-664

2020

Volltextzugriff (PDF)

Risk Prediction of Major Adverse Cardiovascular Events Occurrence Within 6 Months After Coronary Revascularization: Machine Learning Study

JMIR medical informatics, 2022-04, Vol.10 (4), p.e33395-e33395

2022

Volltextzugriff (PDF)

Phase I study of the safety, pharmacokinetics and antitumor activity of famitinib

Cancer chemotherapy and pharmacology, 2013-11, Vol.72 (5), p.1043-1053

2013

Volltextzugriff (PDF)

A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920965849-1758835920965849

2020

Volltextzugriff (PDF)

Vorolanib, an oral VEGFR/PDGFR dual tyrosine kinase inhibitor for treatment of patients with advanced solid tumors: An open-label, phase I dose escalation and dose expansion trial

Chinese journal of cancer research, 2021-02, Vol.33 (1), p.103-114

2021

Volltextzugriff (PDF)

Phase II study of S‐1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off

Cancer science, 2017-10, Vol.108 (10), p.2045-2051

2017

Volltextzugriff (PDF)

Online sequential prediction of bearings imbalanced fault diagnosis by extreme learning machine

Mechanical systems and signal processing, 2017-01, Vol.83, p.450-473

2017

Volltextzugriff (PDF)

A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy

Medical oncology (Northwood, London, England), 2013-03, Vol.30 (1), p.343, Article 343

2013

Volltextzugriff (PDF)

Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma

Clinical cancer research, 2018-11, Vol.24 (21), p.5233-5238

2018

Volltextzugriff (PDF)

Body mass index and age are additional prognostic factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

Urologic oncology, 2016-06, Vol.34 (6), p.258.e15-258.e22

2016

Volltextzugriff (PDF)

An ELM-based model with sparse-weighting strategy for sequential data imbalance problem

International journal of machine learning and cybernetics, 2017-08, Vol.8 (4), p.1333-1345

2017

Volltextzugriff (PDF)

Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer

Thyroid (New York, N.Y.), 2018-11, Vol.28 (11), p.1455-1461

2018

Volltextzugriff (PDF)

Advanced duodenal carcinoma：Chemotherapy efficacy and analysis of prognostic factors

Oncology and translational medicine, 2016-02, Vol.2 (1), p.16-20

2016

Volltextzugriff (PDF)

Determination of gambogic acid in human plasma by liquid chromatography-atmospheric pressure chemical ionization–mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-02, Vol.846 (1), p.112-118

2007

Volltextzugriff (PDF)

Gastroenteropancreatic neuroendocrine tumor registry study in China

Journal of pancreatology (Online), 2018-12, Vol.1 (1), p.35-38

2018

Volltextzugriff (PDF)

Online sequential prediction of imbalance data with two-stage hybrid strategy by extreme learning machine

Neurocomputing (Amsterdam), 2017-10, Vol.261, p.94-105

2017

Volltextzugriff (PDF)

Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial

The oncologist (Dayton, Ohio), 2019-08, Vol.24 (8), p.e702-e708

2019

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(87)
Chinesisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(39)
Humans
(31)
Oncology
(28)
Male
(24)
Female
(23)
Middle Aged
(22)
Adult
(19)
Technology
(19)
Aged
(18)
Disease-Free Survival
(11)
Physical Sciences
(11)
Retrospective Studies
(11)
Chemotherapy
(10)
Treatment Outcome
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Chemistry
(8)
Materials Science
(8)
Neoplasm Staging
(8)
Patients
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

Machine learning for the prediction of minor amputation in University of Texas grade 3 diabetic foot ulcers

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

Machine learning for the prediction of minor amputation in University of Texas grade 3 diabetic foot ulcers

Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)

Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies

Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial

Risk Prediction of Major Adverse Cardiovascular Events Occurrence Within 6 Months After Coronary Revascularization: Machine Learning Study

Phase I study of the safety, pharmacokinetics and antitumor activity of famitinib

A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer

Vorolanib, an oral VEGFR/PDGFR dual tyrosine kinase inhibitor for treatment of patients with advanced solid tumors: An open-label, phase I dose escalation and dose expansion trial

Phase II study of S‐1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off

Online sequential prediction of bearings imbalanced fault diagnosis by extreme learning machine

A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy

Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma

Body mass index and age are additional prognostic factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

An ELM-based model with sparse-weighting strategy for sequential data imbalance problem

Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer

Advanced duodenal carcinoma：Chemotherapy efficacy and analysis of prognostic factors

Determination of gambogic acid in human plasma by liquid chromatography-atmospheric pressure chemical ionization–mass spectrometry

Gastroenteropancreatic neuroendocrine tumor registry study in China

Online sequential prediction of imbalance data with two-stage hybrid strategy by extreme learning machine

Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial

Suchergebnisse filtern